DrugPatentWatch Database Preview

Terazosin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for terazosin hydrochloride and what is the scope of terazosin hydrochloride patent protection?

Terazosin hydrochloride is the generic ingredient in two branded drugs marketed by Abbott, Apotex, Ivax Sub Teva Pharms, Jubilant Cadista, Mylan Pharms Inc, Mylan Technologies, Ranbaxy Labs Ltd, Sandoz, and Teva, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for terazosin hydrochloride. Twenty-four suppliers are listed for this compound.

Summary for terazosin hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	9
NDAs:	14
Drug Master File Entries:	24
Suppliers / Packagers:	24
Bulk Api Vendors:	55
Clinical Trials:	17
Patent Applications:	1,175
Formulation / Manufacturing:	see details
DailyMed Link:	terazosin hydrochloride at DailyMed

Pharmacology for terazosin hydrochloride

Drug Class	alpha-Adrenergic Blocker
Mechanism of Action	Adrenergic alpha-Antagonists

Synonyms for terazosin hydrochloride

(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone hydrochloride

[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone hydrochloride

[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone hydrochloride

074T088

1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)-piperazine hydrochloride

1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonxyl]piperazine Hydrochloride

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-piperazine hydrochloride

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride

141269-45-6

2[4-(Tetrahydro-2-furoy1)piperazinyl]-4-amino-6,7-dimethoxyquinazoline hydrochloride

4-Amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazoline Hydrochloride

6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine hydrochloride

63074-08-8

63590-64-7 (Parent)

AB1009460

AB2000463

Abbott-45975

AC-2074

AC1L2BPY

AK307521

AKOS007930686

AN-14324

BB_SC-1129

C19H25N5O4.HCl

CAS-63074-08-8

CCG-220751

CHEMBL1256665

DB-018541

DSSTox_CID_25493

DSSTox_GSID_45493

DSSTox_RID_80913

DTXSID7045493

EU-0101138

FT-0605647

HMS1570G04

Hytrin

I06-0651

IWSWDOUXSCRCKW-UHFFFAOYSA-N

KS-00000JKM

LP01138

LS-110235

MFCD00467965

MLS000040261

MLS001077301

MLS001305722

MolPort-003-666-790

NCGC00016026-10

NCGC00016903-01

NCGC00094404-01

NCGC00094404-02

NE45355

NSC-759168

NSC759168

Opera_ID_398

Pharmakon1600-01505576

Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, monohydrochloride

Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-,monohydrochloride

Prestwick_146

s4679

SCHEMBL41545

SMR000044015

T 4680

Terazosin HCl

TERAZOSIN HYDROCHLORIDE (anhydrous)

Terazosin hydrochloride anhydrous

Terazosin hydrochloride, >=98% (TLC), powder

Terazosin monohydrochloride anhydrous

terazosine hydrochloride

terazosinhydrochloride

Tetrazosin hydrochloride

TL8004930

Tox21_110674

Tox21_110674_1

TR-037527

TRA0127916

V1531

VA11840

Vasocard

Zayasel

US Patents and Regulatory Information for terazosin hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sandoz	TERAZOSIN HYDROCHLORIDE	terazosin hydrochloride	TABLET;ORAL	074315-004	Dec 31, 1998		DISCN	No	No
Mylan Technologies	TERAZOSIN HYDROCHLORIDE	terazosin hydrochloride	CAPSULE;ORAL	075384-001	Dec 1, 2000		DISCN	No	No
Sandoz	TERAZOSIN HYDROCHLORIDE	terazosin hydrochloride	TABLET;ORAL	074657-004	Apr 28, 2000		DISCN	No	No
Ivax Sub Teva Pharms	TERAZOSIN HYDROCHLORIDE	terazosin hydrochloride	CAPSULE;ORAL	075614-004	Jan 30, 2001	AB	RX	No	No
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-004	Dec 14, 1994		DISCN	Yes	No
Ivax Sub Teva Pharms	TERAZOSIN HYDROCHLORIDE	terazosin hydrochloride	TABLET;ORAL	074530-002	Apr 21, 2000		DISCN	No	No
Ivax Sub Teva Pharms	TERAZOSIN HYDROCHLORIDE	terazosin hydrochloride	TABLET;ORAL	074530-003	Apr 21, 2000		DISCN	No	No

Expired US Patents for terazosin hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-004	Aug 7, 1987
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-004	Dec 14, 1994
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-003	Dec 14, 1994
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-003	Aug 7, 1987
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-004	Aug 7, 1987
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-003	Dec 14, 1994
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-001	Dec 14, 1994